Jump to content

MonkeyDoughnut

Certifiably Surly
  • Posts

    10462
  • Joined

  • Last visited

  • Days Won

    1

Everything posted by MonkeyDoughnut

  1. What we really don't want to happen is Ewers to come back another year because of what that means.
  2. SMU.....man...
  3. Been a long time since seen a QB self destruct so badly from one half to the next.
  4. Was closer than their last 3 FG tries
  5. Is LSUing a thing, because they are definitely LSUing
  6. At this rate don't think he should
  7. Receiver runs open all over the place, just need a decently thrown ball to find them. Assume LSU planning on two plays here if don't get 1st...kicker already failed you multiple times.
  8. Aggy black out at night makes their stadium look empty
  9. Nussmeier looks like a pro playing in college. Very composed
  10. No desire to watch future games... Going to have to work myself up... Offense just doesn't feel things when QE is the guy. You can tell by their body language.
  11. Didn't even have to use a single TO....
  12. Sark making the case for himself being the problem this game
  13. What a horseshit holding call on helm
  14. Defense plays well when offense doesn't screw them over
  15. Sark is hobbling this team playing Ewers.
  16. Stop making pennies and the nickel is the new penny. There will always be a "penny".
  17. Still can't align Baylor's 2021 season and Aranda's coach of the year performance with everything else he's shown at Baylor. It's just not a good fit and he's not head coach material. He seems much more suited as a DC focusing on just one side of the ball.
  18. IBRX Adding news from this morning... Company’s first clinical trial studying CAR-NK (CD19 t-haNK) cellular therapy in liquid tumors First natural killer cell-based cellular therapy study conducted in the continent of Africa Complete enrollment currently expected in Q1 2025 CULVER CITY, Calif., October 24, 2024--(BUSINESS WIRE)--Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), announced today that the first patients have been dosed in an initial trial studying the potential of the company’s CAR-NK cell therapy targeting CD-19 in the treatment of non-Hodgkin’s lymphoma (NHL).
  19. The assistant AD getting pissed off about the questions adds to just how messed up they are. Show a little empathy here. You don't have to add anything more than what the University put out, but check the attitude at least.
  20. I guess they don't feel like self-driving vehicles will be a thing in 10-20 years.
×
×
  • Create New...